Abstract
Objective
To assess the effect of continuous venovenous hemodiafiltration (CVVHDF) in cancer patients with acute renal failure.
Patients and methods
Retrospective study of all patients with acute renal failure requiring dialysis and treated with CVVHDF in a medical intensive care unit (ICU) from a cancer hospital.
Results
From January 1997 until December 2002, 32 cancer patients were treated with CVVHDF for acute renal failure. Their characteristics were: male/female 23/9, median age 61 years, haematological/solid tumours 16/16, and median APACHE II and IGS II scores 31/67. The number of organ failures was 1/2/3/4 in respectively 10/6/13/2 patients. Complete, partial or absence of resolution of acute renal failure was noted in 13, 8 and 11 patients. Sixteen patients (50%) died in the ICU and 15 (47%) were discharged alive from the hospital. In univariate analysis, variables statistically significantly adversely associated with hospital mortality were renal failure of renal origin, bone marrow transplant, increasing number of organ failures, reduced lymphocyte count, elevated bilirubin and lower creatinine levels, increased thromboplastin time, younger age, increased APACHE II and IGS II, ARDS and mechanical ventilation. In multivariate analysis, two models were used including either APACHE II or IGS II. The number of organ failures was found as the only significant prognostic factor in both models (p=0.01). Elevated phosphate level was a poor prognostic factor for hospital mortality (p=0.04) in the model including APACHE II.
Conclusions
In the experience of a single centre, CVVHDF is effective in the treatment of acute renal failure in cancer patients. The increasing number of organ failures was the single independent poor predictive factor for hospital mortality. Cancer characteristics and general gravity scores were not predictive factors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barton IK, Hilton PJ (1993) Veno-venous haemofiltration in the intensive care unit. Clinical Intensive Care 4, 16–22
Cole L, Bellomo R, Silvester W, Reeves JH (2000) A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a “closed” ICU system. Am J Respir Crit Care Med 162:191–196
Cosentino F , Chaff C, Piedmonte M (1994) Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant 9 [Suppl 4]:179–182
Haines IE, Zalcberg J, Buchanan JD (1990) Not-for-resuscitation orders in cancer patients--principles of decision making. Med J Aust 153:225–229
Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, Linde-Zwirble WT (2002) Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28:29–37
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Prognosis in acute organ-system failure. Ann Surg 202:685–693
Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G, Ehninger G, Schuler U (2002) Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 28:1294–1300
Lane PH, Mauer SM, Blazar BR, Ramsay NK, Kashtan CE (1994) Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 13:613–617
Lanore JJ, Brunet F, Pochard F, Bellivier F, Dhainaut JF, Vaxelaire JF, Giraud T, Dreyfus F, Dreyfuss D, Chiche JD (1991) Hemodialysis for acute renal failure in patients with hematologic malignancies. Crit Care Med 19:346–351
Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
Letourneau I, Dorval M, Belanger R, Legare M, Fortier L, Leblanc M (2002) Acute renal failure in bone marrow transplant patients admitted to the intensive care unit. Nephron 90:408–412
Paesmans M, Berghmans T, Lemaitre F, Sculier J P (2000) General APACHE II and SAPS II scoring systems and cancer specific scoring system for cancer patients admitted for an acute complication in a medical intensive care unit: short and long term prognosis. Proc ASCO 20, 237a
Sasaki S, Gando S, Kobayashi S, Nanzaki S, Ushitani T, Morimoto Y, Demmotsu O (2001) Predictors of mortality in patients treated with continuous hemodiafiltration for acute renal failure in an intensive care setting. ASAIO J 47:86–91
Schaefer JH, Jochimsen F, Keller F, Wegscheider K, Distler A (1991) Outcome prediction of acute renal failure in medical intensive care. Intensive Care Med 17:19–24
Schwilk B, Wiedeck H, Stein B, Reinelt H, Treiber H, Bothner U (1997) Epidemiology of acute renal failure and outcome of haemodiafiltration in intensive care. Intensive Care Med 23:1204–1211
Sculier JP, Paesmans M, Markiewicz E, Berghmans T (2000) Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit Care Med 28:2786–2792
Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, Burgmann H, Wilfing A, Kofler J, Thalhammer F, Frass M (2000) Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28:1322–1328
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berghmans, T., Meert, A.P., Markiewicz, E. et al. Continuous venovenous haemofiltration in cancer patients with renal failure: a single-centre experience. Support Care Cancer 12, 306–311 (2004). https://doi.org/10.1007/s00520-003-0588-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-003-0588-8